← FDA Drug Approvals (Drugs@FDA)

EPINEPHRINE

NDA · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2025-03-13

Drug application

FDA Application #

NDA215425

Application type

New Drug Application

Brand name

EPINEPHRINE

Generic name

EPINEPHRINE

Active ingredients

EPINEPHRINE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2025-03-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown